Shared Medical Decision Making in the Prophylactic Treatment of Bipolar Disorder

NCT ID: NCT03245593

Last Updated: 2025-12-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

300 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-04-24

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators hypothesize that implementation of a shared decision making care plan for prophylactic treatment will help therapeutic adherence of bipolar patients. They also anticipate that patients treated according to a shared decision making plan will have an elevated satisfaction of their care, quality of life and functionment, as well as a lower number of relapses

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bipolar Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Shared Decision making for care

Group Type EXPERIMENTAL

Shared-decision making process

Intervention Type OTHER

Completion of the Ottawa Personal Decision Guide to help guide care with the support of online and printed material describing the therapeutic options available

Standard decision making for care

Group Type OTHER

standard care

Intervention Type OTHER

Care of patients according to standard practice of managing patients with bipolar disorder

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Shared-decision making process

Completion of the Ottawa Personal Decision Guide to help guide care with the support of online and printed material describing the therapeutic options available

Intervention Type OTHER

standard care

Care of patients according to standard practice of managing patients with bipolar disorder

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* The patient must have given their free and informed consent and signed the consent form
* The patient must be a member or beneficiary of a health insurance plan
* The patient must be available for the 12 months of follow-up
* The patient is at least 18 years old
* Patients is suffering from bipolar disorder (I or II) according to DSM-5 criteria
* Following resolution of a mood episode (manic or depressive according to DSM-5 criteria) according to the criteria of l'International Society for Bipolar Disorder (Recovery, clinical remission of at least 4 weeks)
* Followed by at least one of the practitioner belonging to one of the participating centers
* Without comprehension problems of fluent French

Exclusion Criteria

* The subject is participating in an interventional study, or has participated in another interventional study within the previous 3 months
* The subject is in a period of exclusion determined by a previous study
* The patient is under safeguard of justice or state guardianship
* It is impossible to give the subject informed information, or the subject refuses to sign the consent
* The subject has already participated in this study
* The patient has troubles linked to the usage of severe intensive substances (such as those defined by the DMS-5)
* The patient has a revision of the initial diagnosis of bipolar disorder
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Universitaire de Nīmes

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ludovic Samalin

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Clermont-Ferrand

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ch Beziers

Béziers, , France

Site Status

CH Charles Perrens

Bordeaux, , France

Site Status

CH le Vinatier

Bron, , France

Site Status

CHU de Clermont Ferrand - Hôpital Gabriel-Montpied

Clermont-Ferrand, , France

Site Status

Chu Gabriel Montpied Clermont Ferrand

Clermont-Ferrand, , France

Site Status

CH Sainte-Marie de Clermont-Ferrand

Clermont-Ferrand, , France

Site Status

APHP - Centre Hospitalier Henri Mondor

Créteil, , France

Site Status

CHU de Grenoble - Hôpital Albert Michallon

Grenoble, , France

Site Status

CH Limoges

Limoges, , France

Site Status

APHM - Hôpital Sainte-Marguerite

Marseille, , France

Site Status

CHU de Montpellier - Hôpital Lapeyronie

Montpellier, , France

Site Status

CHU Nancy

Nancy, , France

Site Status

CHU Nantes

Nantes, , France

Site Status

Clinique des troubles thymiques

Nîmes, , France

Site Status

CHU Nimes

Nîmes, , France

Site Status

APHP - Hôpital Saint Louis-Lariboisière-Fernand-Widal

Paris, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

References

Explore related publications, articles, or registry entries linked to this study.

Samalin L, Honciuc M, Boyer L, de Chazeron I, Blanc O, Abbar M, Llorca PM. Efficacy of shared decision-making on treatment adherence of patients with bipolar disorder: a cluster randomized trial (ShareD-BD). BMC Psychiatry. 2018 Apr 13;18(1):103. doi: 10.1186/s12888-018-1686-y.

Reference Type DERIVED
PMID: 29653535 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PREPS/2016/LS-01

Identifier Type: -

Identifier Source: org_study_id